{"id":407486,"date":"2021-01-04T08:33:28","date_gmt":"2021-01-04T13:33:28","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=407486"},"modified":"2021-01-04T08:33:28","modified_gmt":"2021-01-04T13:33:28","slug":"bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/","title":{"rendered":"Bellerophon to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">WARREN, N.J., Jan.  04, 2021  (GLOBE NEWSWIRE) &#8212; Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (\u201cBellerophon\u201d or the \u201cCompany\u201d), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious diseases, today announced that Fabian Tenenbaum, Chief Executive Officer, will present a corporate overview at the H.C. Wainwright Virtual BioConnect 2021 Conference, being held January 11-14, 2021.<\/p>\n<p align=\"justify\">The presentation will be available on-demand beginning on Monday, January 11, 2021, in the Investors section on the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SMjc9r8smuxZlZAAHTEJPmZZLYwJcvo-q7eJDXgAHCra1ufce8WtnLAKhYVKqIHV5Qk5Ph7RVOKl886NgNdPo996OWIGbcaWlP8cuh-fIN0=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.bellerophon.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About Bellerophon<\/strong><br \/>\n        <br \/>Bellerophon Therapeutics\u00a0is a clinical-stage biotherapeutics company focused on developing innovative therapies that address significant unmet medical needs in the treatment of cardiopulmonary and infectious diseases. The Company is currently developing multiple product candidates under its INOpulse<sup>\u00ae<\/sup>\u00a0program, a proprietary pulsatile nitric oxide delivery system. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SMjc9r8smuxZlZAAHTEJPlolrkJQ3z9Bmdg79ZrzbLI2Ma6PXHxukBJDOBvoGDBLnrZjCiApHyMSk_W91qRlC5lOZ6QjV9AMV2Jex0PyWNs=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.bellerophon.com<\/a>.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:30%;width:30%;min-width:30%\">\n            <strong>Contacts<\/strong>\n          <\/td>\n<td style=\"max-width:1%;width:1%;min-width:1%\">\u00a0<\/td>\n<td style=\"max-width:69%;width:69%;min-width:69%\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td>\n            <strong>At W2O Group:<\/strong>\n          <\/td>\n<td>\u00a0<\/td>\n<td>\n            <strong>At LifeSci Advisors:<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td>Julie Normart<\/td>\n<td>\u00a0<\/td>\n<td>Brian Ritchie<\/td>\n<\/tr>\n<tr>\n<td>(559) 974-3245<\/td>\n<td>\u00a0<\/td>\n<td>(212) 915-2578<\/td>\n<\/tr>\n<tr>\n<td>\n            <a href=\"mailto:jnormart@w2ogroup.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">jnormart@w2ogroup.com<\/a>\n          <\/td>\n<td>\u00a0<\/td>\n<td>\n            <a href=\"mailto:britchie@lifesciadvisors.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">britchie@lifesciadvisors.com<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p>\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExODQ4OSMzODk4Nzg0IzIwMTE0NzU=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/5cadcf90-edd5-4f52-86d1-ab6db34ad80c\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WARREN, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) &#8212; Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (\u201cBellerophon\u201d or the \u201cCompany\u201d), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious diseases, today announced that Fabian Tenenbaum, Chief Executive Officer, will present a corporate overview at the H.C. Wainwright Virtual BioConnect 2021 Conference, being held January 11-14, 2021. The presentation will be available on-demand beginning on Monday, January 11, 2021, in the Investors section on the Company\u2019s website at www.bellerophon.com. About Bellerophon Bellerophon Therapeutics\u00a0is a clinical-stage biotherapeutics company focused on developing innovative therapies that address significant unmet medical needs in the treatment of cardiopulmonary and infectious diseases. The Company is currently developing multiple product candidates under its INOpulse\u00ae\u00a0program, a proprietary pulsatile nitric &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Bellerophon to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-407486","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bellerophon to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bellerophon to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WARREN, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) &#8212; Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (\u201cBellerophon\u201d or the \u201cCompany\u201d), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious diseases, today announced that Fabian Tenenbaum, Chief Executive Officer, will present a corporate overview at the H.C. Wainwright Virtual BioConnect 2021 Conference, being held January 11-14, 2021. The presentation will be available on-demand beginning on Monday, January 11, 2021, in the Investors section on the Company\u2019s website at www.bellerophon.com. About Bellerophon Bellerophon Therapeutics\u00a0is a clinical-stage biotherapeutics company focused on developing innovative therapies that address significant unmet medical needs in the treatment of cardiopulmonary and infectious diseases. The Company is currently developing multiple product candidates under its INOpulse\u00ae\u00a0program, a proprietary pulsatile nitric &hellip; Continue reading &quot;Bellerophon to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-04T13:33:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExODQ4OSMzODk4Nzg0IzIwMTE0NzU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Bellerophon to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference\",\"datePublished\":\"2021-01-04T13:33:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\\\/\"},\"wordCount\":164,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExODQ4OSMzODk4Nzg0IzIwMTE0NzU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\\\/\",\"name\":\"Bellerophon to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExODQ4OSMzODk4Nzg0IzIwMTE0NzU=\",\"datePublished\":\"2021-01-04T13:33:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExODQ4OSMzODk4Nzg0IzIwMTE0NzU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExODQ4OSMzODk4Nzg0IzIwMTE0NzU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bellerophon to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bellerophon to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/","og_locale":"en_US","og_type":"article","og_title":"Bellerophon to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference - Market Newsdesk","og_description":"WARREN, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) &#8212; Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (\u201cBellerophon\u201d or the \u201cCompany\u201d), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious diseases, today announced that Fabian Tenenbaum, Chief Executive Officer, will present a corporate overview at the H.C. Wainwright Virtual BioConnect 2021 Conference, being held January 11-14, 2021. The presentation will be available on-demand beginning on Monday, January 11, 2021, in the Investors section on the Company\u2019s website at www.bellerophon.com. About Bellerophon Bellerophon Therapeutics\u00a0is a clinical-stage biotherapeutics company focused on developing innovative therapies that address significant unmet medical needs in the treatment of cardiopulmonary and infectious diseases. The Company is currently developing multiple product candidates under its INOpulse\u00ae\u00a0program, a proprietary pulsatile nitric &hellip; Continue reading \"Bellerophon to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-04T13:33:28+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExODQ4OSMzODk4Nzg0IzIwMTE0NzU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Bellerophon to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference","datePublished":"2021-01-04T13:33:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/"},"wordCount":164,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExODQ4OSMzODk4Nzg0IzIwMTE0NzU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/","name":"Bellerophon to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExODQ4OSMzODk4Nzg0IzIwMTE0NzU=","datePublished":"2021-01-04T13:33:28+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExODQ4OSMzODk4Nzg0IzIwMTE0NzU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExODQ4OSMzODk4Nzg0IzIwMTE0NzU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bellerophon-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Bellerophon to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/407486","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=407486"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/407486\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=407486"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=407486"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=407486"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}